Publications by authors named "Hyang Nina Kim"
Article Synopsis
- The study aimed to predict the prevalence of comorbidities and multimorbidity among people living with HIV in the US by 2030, utilizing the PEARL agent-based simulation model.
- It forecasted that the population of individuals on antiretroviral therapy (ART) will grow from 670,000 in 2020 to 908,000 by 2030, reflecting increases among various demographic groups, including Hispanic and Black/African American individuals.
- Key findings indicated a rise in mental health issues like depression and anxiety, projecting an increase from 60% to 64% prevalence, while hypertension was expected to decrease.
Objectives: To define the incidence of clinically detected coronavirus disease 2019 (COVID-19) in people with HIV (PWH) in the United States and evaluate how racial and ethnic disparities, comorbidities, and HIV-related factors contribute to risk of COVID-19.
Design: Observational study within the CFAR Network of Integrated Clinical Systems cohort in seven cities during 2020.
Methods: We calculated cumulative incidence rates of COVID-19 diagnosis among PWH in routine care by key characteristics including race/ethnicity, current and lowest CD4+ cell count, and geographic area.
Objectives: We examined how patient perceptions of alcohol risk, provider discussions about alcohol, and treatment of hepatitis C virus (HCV) differed among HIV-HCV coinfected patients in primary care.
Methods: Between April, 2016 and April, 2017, we conducted a screening survey with patients in an HIV primary care clinic in Seattle, Washington, who had chronic HCV coinfection or a history of chronic HCV infection who had successfully cleared their infection with treatment.
Results: Of 225 participants, 84 (37%) were active drinkers (drank ≥2-4 times/mo in past 3 months).